Fumiaki Urase

557 total citations
22 papers, 439 citations indexed

About

Fumiaki Urase is a scholar working on Oncology, Epidemiology and Hematology. According to data from OpenAlex, Fumiaki Urase has authored 22 papers receiving a total of 439 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 6 papers in Epidemiology and 5 papers in Hematology. Recurrent topics in Fumiaki Urase's work include Adipokines, Inflammation, and Metabolic Diseases (4 papers), Eosinophilic Disorders and Syndromes (3 papers) and Cardiovascular Disease and Adiposity (2 papers). Fumiaki Urase is often cited by papers focused on Adipokines, Inflammation, and Metabolic Diseases (4 papers), Eosinophilic Disorders and Syndromes (3 papers) and Cardiovascular Disease and Adiposity (2 papers). Fumiaki Urase collaborates with scholars based in Japan and United States. Fumiaki Urase's co-authors include Shosaku� Nomura, Norihito Inami, Akira Shouzu, Yasuhiro Maeda, Seitarou Omoto, Yasuhiro Maeda, Yutaka Kimura, Toshiji Iwasaka, Tetsuya Ueba and Atsushi Tanaka and has published in prestigious journals such as Clinical Pharmacology & Therapeutics, British Journal of Haematology and Thrombosis and Haemostasis.

In The Last Decade

Fumiaki Urase

22 papers receiving 426 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Fumiaki Urase Japan	9	158	153	94	77	70	22	439
Xiaoli Cao China	14	103 0.7×	132 0.9×	111 1.2×	51 0.7×	42 0.6×	32	525
Mark W. Hazel United States	8	183 1.2×	150 1.0×	97 1.0×	23 0.3×	44 0.6×	15	473
Shigenori Kanazawa Japan	11	157 1.0×	132 0.9×	25 0.3×	76 1.0×	41 0.6×	23	419
Samad Barzegar United States	9	173 1.1×	319 2.1×	88 0.9×	141 1.8×	58 0.8×	11	810
María Eugenia de la Morena‐Barrio Spain	16	259 1.6×	458 3.0×	97 1.0×	89 1.2×	35 0.5×	67	798
Behnoush Parviz Germany	10	149 0.9×	91 0.6×	31 0.3×	59 0.8×	33 0.5×	18	413
R. Sartorio Italy	9	152 1.0×	201 1.3×	27 0.3×	111 1.4×	30 0.4×	13	619
Jean-Marie Freyssinet France	8	217 1.4×	143 0.9×	28 0.3×	31 0.4×	60 0.9×	8	544
Paula S. Howes United States	7	74 0.5×	258 1.7×	151 1.6×	24 0.3×	43 0.6×	9	451
Fariborz Rashid-Kolvear Canada	9	254 1.6×	114 0.7×	47 0.5×	38 0.5×	71 1.0×	19	471

Countries citing papers authored by Fumiaki Urase

Since Specialization

Citations

This map shows the geographic impact of Fumiaki Urase's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fumiaki Urase with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fumiaki Urase more than expected).

Fields of papers citing papers by Fumiaki Urase

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fumiaki Urase. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fumiaki Urase. The network helps show where Fumiaki Urase may publish in the future.

Co-authorship network of co-authors of Fumiaki Urase

This figure shows the co-authorship network connecting the top 25 collaborators of Fumiaki Urase. A scholar is included among the top collaborators of Fumiaki Urase based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fumiaki Urase. Fumiaki Urase is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Morita, Yasuyoshi, Yasuhiro Maeda, Terufumi Yamaguchi, et al.. (2018). Five‐day regimen of azacitidine for lower‐risk myelodysplastic syndromes (refractory anemia or refractory anemia with ringed sideroblasts): A prospective single‐arm phase 2 trial. Cancer Science. 109(10). 3209–3215. 10 indexed citations

Koh, Hideo, Masayuki Hino, Kensuke Ohta, et al.. (2013). Empirical voriconazole therapy for febrile neutropenic patients with hematological disorders: a prospective multicenter trial in Japan. Journal of Infection and Chemotherapy. 19(6). 1126–1134. 5 indexed citations

Takahashi, Naoto, Hisashi Wakita, Masatomo Miura, et al.. (2010). Correlation Between Imatinib Pharmacokinetics and Clinical Response in Japanese Patients With Chronic-Phase Chronic Myeloid Leukemia. Clinical Pharmacology & Therapeutics. 88(6). 809–813. 76 indexed citations

Ishii, Kazuyoshi�, Fumiaki Urase, Masahiro Manabe, et al.. (2009). VNCOP-B plus rituximab therapy in elderly patients with aggressive B-cell non-Hodgkin lymphoma: A multicenter experience. Archives of Gerontology and Geriatrics. 51(2). 209–215. 7 indexed citations

Nomura, Shosaku�, Norihito Inami, Akira Shouzu, et al.. (2009). The effects of pitavastatin, eicosapentaenoic acid and combined therapy on platelet-derived microparticles and adiponectin in hyperlipidemic, diabetic patients. Platelets. 20(1). 16–22. 91 indexed citations

Nomura, Shosaku�, Akira Shouzu, Seitarou Omoto, et al.. (2009). Effects of pitavastatin on monocyte chemoattractant protein-1 in hyperlipidemic patients. Blood Coagulation & Fibrinolysis. 20(6). 440–447. 25 indexed citations

Nomura, Shosaku�, Kazuyoshi� Ishii, Norihito Inami, et al.. (2009). The significance of EMAP-II after allogeneic stem cell transplantation. Transplant Immunology. 21(1). 23–26. 6 indexed citations

Nomura, Shosaku�, Norihito Inami, Akira Shouzu, Fumiaki Urase, & Yasuhiro Maeda. (2009). Correlation and association between plasma platelet-, monocyte- and endothelial cell-derived microparticles in hypertensive patients with type 2 diabetes mellitus. Platelets. 20(6). 406–414. 46 indexed citations

Nomura, Shosaku�, Akira Shouzu, Seitarou Omoto, et al.. (2009). Effects of Eicosapentaenoic Acid on Endothelial Cell-Derived Microparticles, Angiopoietins and Adiponectin in Patients with Type 2 Diabetes. Journal of Atherosclerosis and Thrombosis. 16(2). 83–90. 53 indexed citations

10.

Ishii, Kazuyoshi�, Satoshi Suzuki, Yoshio Matsuo, et al.. (2009). The significance of ADAMTS13 in a patient with thrombotic thrombocytopenic purpura complicated autoimmune hepatitis. Thrombosis and Haemostasis. 101(3). 599–600. 4 indexed citations

11.

Inami, Norihito, Shosaku� Nomura, Yutaka Kimura, et al.. (2008). Significance of soluble CD40 ligand, adiponectin and reactive oxygen metabolites in aging. Archives of Gerontology and Geriatrics. 49(1). 13–16. 7 indexed citations

12.

Nozaki, Yuji, et al.. (2008). A case of Behcet's disease in a patient with albinism. Japanese Journal of Clinical Immunology. 31(1). 68–70. 1 indexed citations

13.

Nomura, Shosaku�, Kazuyoshi� Ishii, Norihito Inami, et al.. (2008). Evaluation of Angiopoietins and Cell-Derived Microparticles after Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 14(7). 766–774. 36 indexed citations

14.

Nomura, Shosaku�, et al.. (2007). Elevation of Activated Platelet-Dependent Chemokines and Soluble Cell Adhesion Molecules in Patients with Hematologic Malignancies and High Levels of β-<i>D</i>-Glucan. Pathophysiology of Haemostasis and Thrombosis. 36(1). 32–39. 1 indexed citations

15.

Nozaki, Yuji, et al.. (2007). Successful treatment using tacrolimus plus corticosteroid in a patient with RA associated with MDS. Rheumatology International. 28(5). 487–490. 4 indexed citations

16.

Ishii, Kazuyoshi�, Y. Yamamoto, Hitoshi Kitayama, et al.. (2005). [VNCOP-B (etoposide, mitoxantrone, cyclophosphamide, vincristine, predonisolone, bleomycin) therapy in elderly patients with aggressive non-Hodgkin lymphoma--a study of efficacy and safety, final report].. PubMed. 32(1). 39–44. 1 indexed citations

17.

Maeda, Yasuhiro, Junichi Chihara, Junichi Miyatake, et al.. (1996). Elevated levels of soluble ICAM-1 in serum of patients with acute myeloid leukemia undergoing bone marrow transplantation. American Journal of Hematology. 52(3). 227–228. 2 indexed citations

18.

Maeda, Yasuhiro, Junichi Miyatake, Hiroshi Sono, et al.. (1996). Inhibition of growth and induction of apoptosis by all‐trans retinoic acid in lymphoid cell lines transfected with the PML/RARα fusion gene. British Journal of Haematology. 93(4). 973–976. 10 indexed citations

19.

Ariyama, Takeshi, Johji Inazawa, Yoshiki Uemura, et al.. (1995). Clonal origin of Philadelphia chromosome negative cells with trisomy 8 appearing during the course of α-interferon therapy for Ph positive chronic myelocytic leukemia. Cancer Genetics and Cytogenetics. 81(1). 20–23. 43 indexed citations

20.

Ashida, Takashi, et al.. (1994). Change of serum alpha-1 microglobulin and beta-2 microglobulin following allogeneic bone marrow transplantation.. PubMed. 14(4). 579–82. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact